Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy

As a complex multicellular structure of the vascular system at the central nervous system (CNS), the blood-brain barrier (BBB) separates the CNS from the system circulation and regulates the influx and efflux of substances to maintain the steady-state environment of the CNS. Lipopolysaccharide (LPS)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaoyao Peng, Zhixuan Luo, Shuang He, Luhua Zhang, Ying Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/11154dca68374e908ec6e1d570fc4763
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11154dca68374e908ec6e1d570fc4763
record_format dspace
spelling oai:doaj.org-article:11154dca68374e908ec6e1d570fc47632021-11-04T05:06:31ZBlood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy2235-298810.3389/fcimb.2021.768108https://doaj.org/article/11154dca68374e908ec6e1d570fc47632021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcimb.2021.768108/fullhttps://doaj.org/toc/2235-2988As a complex multicellular structure of the vascular system at the central nervous system (CNS), the blood-brain barrier (BBB) separates the CNS from the system circulation and regulates the influx and efflux of substances to maintain the steady-state environment of the CNS. Lipopolysaccharide (LPS), the cell wall component of Gram-negative bacteria, can damage the barrier function of BBB and further promote the occurrence and development of sepsis-associated encephalopathy (SAE). Here, we conduct a literature review of the direct and indirect damage mechanisms of LPS to BBB and the relationship between these processes and SAE. We believe that after LPS destroys BBB, a large number of inflammatory factors and neurotoxins will enter and damage the brain tissue, which will activate brain immune cells to mediate inflammatory response and in turn further destroys BBB. This vicious circle will ultimately lead to the progression of SAE. Finally, we present a succinct overview of the treatment of SAE by restoring the BBB barrier function and summarize novel opportunities in controlling the progression of SAE by targeting the BBB.Xiaoyao PengZhixuan LuoShuang HeLuhua ZhangYing LiFrontiers Media S.A.articleblood-brain barrierlipopolysaccharidesepsis-associated encephalopathycentral nervous systeminflammationoxidative stressMicrobiologyQR1-502ENFrontiers in Cellular and Infection Microbiology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic blood-brain barrier
lipopolysaccharide
sepsis-associated encephalopathy
central nervous system
inflammation
oxidative stress
Microbiology
QR1-502
spellingShingle blood-brain barrier
lipopolysaccharide
sepsis-associated encephalopathy
central nervous system
inflammation
oxidative stress
Microbiology
QR1-502
Xiaoyao Peng
Zhixuan Luo
Shuang He
Luhua Zhang
Ying Li
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
description As a complex multicellular structure of the vascular system at the central nervous system (CNS), the blood-brain barrier (BBB) separates the CNS from the system circulation and regulates the influx and efflux of substances to maintain the steady-state environment of the CNS. Lipopolysaccharide (LPS), the cell wall component of Gram-negative bacteria, can damage the barrier function of BBB and further promote the occurrence and development of sepsis-associated encephalopathy (SAE). Here, we conduct a literature review of the direct and indirect damage mechanisms of LPS to BBB and the relationship between these processes and SAE. We believe that after LPS destroys BBB, a large number of inflammatory factors and neurotoxins will enter and damage the brain tissue, which will activate brain immune cells to mediate inflammatory response and in turn further destroys BBB. This vicious circle will ultimately lead to the progression of SAE. Finally, we present a succinct overview of the treatment of SAE by restoring the BBB barrier function and summarize novel opportunities in controlling the progression of SAE by targeting the BBB.
format article
author Xiaoyao Peng
Zhixuan Luo
Shuang He
Luhua Zhang
Ying Li
author_facet Xiaoyao Peng
Zhixuan Luo
Shuang He
Luhua Zhang
Ying Li
author_sort Xiaoyao Peng
title Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
title_short Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
title_full Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
title_fullStr Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
title_full_unstemmed Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
title_sort blood-brain barrier disruption by lipopolysaccharide and sepsis-associated encephalopathy
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/11154dca68374e908ec6e1d570fc4763
work_keys_str_mv AT xiaoyaopeng bloodbrainbarrierdisruptionbylipopolysaccharideandsepsisassociatedencephalopathy
AT zhixuanluo bloodbrainbarrierdisruptionbylipopolysaccharideandsepsisassociatedencephalopathy
AT shuanghe bloodbrainbarrierdisruptionbylipopolysaccharideandsepsisassociatedencephalopathy
AT luhuazhang bloodbrainbarrierdisruptionbylipopolysaccharideandsepsisassociatedencephalopathy
AT yingli bloodbrainbarrierdisruptionbylipopolysaccharideandsepsisassociatedencephalopathy
_version_ 1718445192730640384